Year |
Citation |
Score |
2017 |
Gonzalez-Gronow M, Fiedler JL, Farias Gomez C, Wang F, Ray R, Ferrell PD, Pizzo SV. Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains. Biochemical and Biophysical Research Communications. PMID 28648598 DOI: 10.1016/J.Bbrc.2017.06.131 |
0.368 |
|
2015 |
Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Blanco A, Sandoval R, Gomez CF, Valenzuela JA, Ray R, Pizzo SV. Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus. Journal of Neuroimmunology. 287: 1-8. PMID 26439953 DOI: 10.1016/J.Jneuroim.2015.07.006 |
0.301 |
|
2014 |
Gonzalez-Gronow M, Gomez CF, de Ridder GG, Ray R, Pizzo SV. Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro. The Journal of Biological Chemistry. 289: 25166-76. PMID 25059665 DOI: 10.1074/Jbc.M114.589341 |
0.408 |
|
2013 |
Gonzalez-Gronow M, Ray R, Wang F, Pizzo SV. The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface. The Journal of Biological Chemistry. 288: 498-509. PMID 23161549 DOI: 10.1074/Jbc.M112.412502 |
0.376 |
|
2013 |
Ridder GGd, Ray R, Pizzo SV. Abstract 5248: Tunneling nanotubes connect melanoma cells and mediate transfer of mitochondria and GRP78. Cancer Research. 73: 5248-5248. DOI: 10.1158/1538-7445.Am2013-5248 |
0.378 |
|
2013 |
Ray R, Ridder Gd, Pizzo SV. Abstract 1247: Development of GRP78 scFv-Subtilase fusion proteins for sensitization of melanoma to chemotherapeutics. Cancer Research. 73: 1247-1247. DOI: 10.1158/1538-7445.Am2013-1247 |
0.435 |
|
2012 |
Ray R, de Ridder GG, Eu JP, Paton AW, Paton JC, Pizzo SV. The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signaling. The Journal of Biological Chemistry. 287: 32755-69. PMID 22851173 DOI: 10.1074/Jbc.M112.399808 |
0.335 |
|
2012 |
de Ridder GG, Ray R, Pizzo SV. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice. Melanoma Research. 22: 225-35. PMID 22495669 DOI: 10.1097/Cmr.0B013E32835312Fd |
0.321 |
|
2011 |
de Ridder G, Ray R, Misra UK, Pizzo SV. Modulation of the unfolded protein response by GRP78 in prostate cancer. Methods in Enzymology. 489: 245-57. PMID 21266234 DOI: 10.1016/B978-0-12-385116-1.00014-5 |
0.41 |
|
2011 |
de Ridder GG, Gonzalez-Gronow M, Ray R, Pizzo SV. Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma. Melanoma Research. 21: 35-43. PMID 21164368 DOI: 10.1097/Cmr.0B013E3283426805 |
0.309 |
|
2003 |
Ray R, Haystead TA. Phosphoproteome analysis in yeast. Methods in Enzymology. 366: 95-103. PMID 14674242 DOI: 10.1016/S0076-6879(03)66008-8 |
0.57 |
|
2003 |
Ray R, Haystead TA. Mixed peptide sequencing and the FASTF/FASTS algorithms. Methods in Enzymology. 366: 84-95. PMID 14674241 DOI: 10.1016/S0076-6879(03)66007-6 |
0.545 |
|
2002 |
Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Molecular Pharmacology. 62: 1364-72. PMID 12435804 DOI: 10.1124/Mol.62.6.1364 |
0.344 |
|
Show low-probability matches. |